Reuters logo
BRIEF-Imprimis Pharmaceuticals Q3 loss per share $‍0.28​
November 14, 2017 / 9:06 PM / in a month

BRIEF-Imprimis Pharmaceuticals Q3 loss per share $‍0.28​

Nov 14 (Reuters) - Imprimis Pharmaceuticals Inc

* Imprimis Pharmaceuticals announces third quarter 2017 results

* Q3 revenue rose 34 percent to $6.5 million

* Imprimis Pharmaceuticals inc qtrly loss per share $‍0.28​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below